Olympic Games Illustrations - Marseille

Olympic Games Illustrations - Marseille

A slogan against the Paris 2024 Olympic Games tagged on a wall in the Réformés district of Marseille, France on May 9, 2024. Photo by Laurent Coust/ABACAPRESS.COM

  • Product Code
  • ILEA002704768
  • Registered date
  • 2024/5/09 00:00:00
  • Credit
  • Abaca Press / Kyodo News Images
  • Media source
  • Coust Laurent/ABACA
  • Media size
  • 4032 × 2688 pixel
  • Resolution
  • 300 dpi
  • Deployment size
  • 2.90(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    coust-doli

    coust-doli

    Illustration of Lysopaine boxe from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
      coust-doli

      coust-doli

      Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
        coust-doli

        coust-doli

        Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
          coust-doli

          coust-doli

          Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
            coust-doli

            coust-doli

            Illustration of Doliprane tablet from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
              coust-doli

              coust-doli

              Illustration of Doliprane boxe from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
                coust-doli

                coust-doli

                Illustration of Doliprane boxe from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
                  coust-doli

                  coust-doli

                  Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
                    Jo Di Bona Pays Tribute To Paris 2024 Athletes - Paris

                    Jo Di Bona Pays Tribute To Paris 2024 Athletes - Paris

                    Artist Jo Di Bona is paying tribute to the athletes of the 2024 Olympics on the railings of Quartier Jeunes (Paris Centre). The athletes include many stars, such as gymnast Simone Biles, swimmer Léon Marchand, pole vault record-holder Armand Duplantis, table tennis champions Félix and Alexis Lebrun, rugby player Antoine Dupont, Brazilian para-swimming champion Gabriel dos Santos Araújo and France's Aurélie Aubert. Paris, France, October 1, 2024. Photo by Denis Prezat/ABACAPRESS.COM
                      Jo Di Bona Pays Tribute To Paris 2024 Athletes - Paris

                      Jo Di Bona Pays Tribute To Paris 2024 Athletes - Paris

                      Artist Jo Di Bona is paying tribute to the athletes of the 2024 Olympics on the railings of Quartier Jeunes (Paris Centre). The athletes include many stars, such as gymnast Simone Biles, swimmer Léon Marchand, pole vault record-holder Armand Duplantis, table tennis champions Félix and Alexis Lebrun, rugby player Antoine Dupont, Brazilian para-swimming champion Gabriel dos Santos Araújo and France's Aurélie Aubert. Paris, France, October 1, 2024. Photo by Denis Prezat/ABACAPRESS.COM